Pfizer’s Effort To Remove Chantix Boxed Warning May Backfire
This article was originally published in The Pink Sheet Daily
Executive Summary
Most FDA advisory committee members vote to wait until clinical trial results are submitted, but some also say warning should be include additional adverse events.